Literature DB >> 19365283

Blood pressure-lowering effects of statins: who benefits?

Leonelo E Bautista1.   

Abstract

OBJECTIVES: To evaluate if the effect of statins on blood pressure is similar in patients grouped by use of antihypertensive medication, level of blood pressure, and high-density lipoprotein cholesterol (HDL-C).
METHODS: Blood pressure was compared in statins users (n = 995) and nonusers (n = 9536) from the National Health and Nutrition Examination Surveys. The overall effect of statins and their interactions with antihypertensive medication, blood pressure, and HDL-C were estimated using multiple linear and quantile regression.
RESULTS: Adjusted systolic blood pressure was on average 1.8 mmHg lower in statins users than in nonusers (P = 0.05). Although statins had no significant effect among nonusers, it decreased systolic blood pressure by 3.3 mmHg among users of antihypertensive medication (interaction P = 0.02). The effect of statins on systolic blood pressure was similar in individuals with HDL-C levels above and below the median (49 mg/dl). Statins also lowered diastolic blood pressure by an average of 1.9 mmHg (P < 0.01), regardless of antihypertensive medication use. Among individuals with high HDL-C statins did not lower diastolic blood pressure, whereas in those with low HDL-C diastolic blood pressure was reduced by 3.4 mmHg. The effect of statins on systolic and diastolic blood pressure increased with higher blood pressure and changed little with adjustment for total cholesterol.
CONCLUSION: Statins lower blood pressure by cholesterol-independent mechanisms, and the reduction is larger in individuals with higher blood pressure and those with low HDL-C. Statins may be beneficial in preventing hypertension and may contribute to better blood pressure control in hypertensive patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19365283     DOI: 10.1097/HJH.0b013e32832b1e78

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.

Authors:  Piero Ruggenenti; Annalisa Perna; Marcello Tonelli; Giacomina Loriga; Nicola Motterlini; Nadia Rubis; Franca Ledda; Stefano Rota; Andrea Satta; Antonio Granata; Giovanni Battaglia; Francesco Cambareri; Salvatore David; Flavio Gaspari; Nadia Stucchi; Sergio Carminati; Bogdan Ene-Iordache; Paolo Cravedi; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

2.  Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial.

Authors:  Giuseppe Mancia; Gianfranco Parati; Miriam Revera; Grzegorz Bilo; Andrea Giuliano; Fabrizio Veglia; Gaetano Crepaldi; Alberto Zanchetti
Journal:  BMJ       Date:  2010-03-25

3.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

4.  Statin therapy reduces the likelihood of suboptimal blood pressure control among Ugandan adult diabetic patients.

Authors:  William Lumu; Leaticia Kampiire; George Patrick Akabwai; Daniel Ssekikubo Kiggundu; Davis Kibirige
Journal:  Ther Clin Risk Manag       Date:  2017-02-20       Impact factor: 2.423

5.  Machine learning of big data in gaining insight into successful treatment of hypertension.

Authors:  Gideon Koren; Galia Nordon; Kira Radinsky; Varda Shalev
Journal:  Pharmacol Res Perspect       Date:  2018-04-24

6.  High Remnant Cholesterol Level Potentiates the Development of Hypertension.

Authors:  Ming-Ming Chen; Xuewei Huang; Chengsheng Xu; Xiao-Hui Song; Ye-Mao Liu; Dongai Yao; Huiming Lu; Gang Wang; Gui-Lan Zhang; Ze Chen; Tao Sun; Chengzhang Yang; Fang Lei; Juan-Juan Qin; Yan-Xiao Ji; Peng Zhang; Xiao-Jing Zhang; Lihua Zhu; Jingjing Cai; Feng Wan; Zhi-Gang She; Hongliang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-09       Impact factor: 5.555

7.  Pleiotropic and Lipid-lowering Effects of Statins in Hypertension.

Authors:  Lulzim Selim Kamberi; Aurora Bedri Bakalli; Norma Muhamet Budima; Daut Rashit Gorani; Ahmet Muzaffer Karabulut; Kelmend Talat Pallaska
Journal:  Mater Sociomed       Date:  2012

8.  Synergistic effects of HMG-CoA reductase inhibitor and angiotensin II receptor blocker on load-induced heart failure.

Authors:  Yusuke Ito; Yasuhiro Maejima; Natsuko Tamura; Yuka Shiheido-Watanabe; Masanori Konishi; Takashi Ashikaga; Kenzo Hirao; Mitsuaki Isobe
Journal:  FEBS Open Bio       Date:  2018-04-10       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.